TSX higher on employment data
CAMBRIDGE, UK - Professor Sir Christopher Evans, founder and Chief Scientific Officer of EDX Medical Group plc (AQSE:EDX), has purchased 26,725 ordinary shares in the company at 10.88 pence per share, according to a statement released Wednesday.
The transaction, which took place on Monday, increases Evans’ total ownership to 135,992,439 shares, representing 36.54% of the company’s issued share capital.
EDX Medical, which is listed on the Apex Segment of the AQSE Growth Market, develops diagnostic products and services focused on cancer, heart disease, and infectious diseases. The company aims to improve disease detection and treatment personalization through biological and digital technologies.
The Cambridge-based firm operates facilities in both Cambridge and Oxford, and maintains strategic partnerships with organizations including Thermo Fisher EMEA Ltd.
The information regarding the share purchase was disclosed in a regulatory filing as part of the company’s obligations to report transactions by persons discharging managerial responsibilities.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.